Lactose Granules are pharmaceutical excipient granules based on lactose, a carbohydrate widely used in pharmaceutical formulation development. Lactose is a disaccharide composed of glucose and galactose and is available in different physical forms, including lactose monohydrate and anhydrous lactose. USP-NF maintains separate monographs for Lactose Monohydrate and Anhydrous Lactose, making the specific lactose form an important consideration when defining a pharmaceutical-grade product.
Lactose Granules are developed to provide a controlled granulated form of lactose for pharmaceutical processing and formulation applications. Granulation can modify the physical handling characteristics of lactose, including particle-size distribution, flow behavior, bulk density and powder-processing performance.
Lactose Granules are granulated pharmaceutical excipient particles containing lactose as the principal component. Depending on the manufacturing process and product specification, the material may be based on lactose monohydrate, anhydrous lactose or a defined combination of lactose forms.
Lactose is commonly used as a pharmaceutical diluent or filler in oral solid formulations. Its physical properties can make it useful for blending and dosage-form manufacturing.
The final characteristics of Lactose Granules depend on the lactose grade, granulation process, particle-size distribution, moisture level and other manufacturing parameters.
Lactose is an established pharmaceutical excipient used in the development of oral solid dosage forms and other pharmaceutical formulations. It can function primarily as a diluent or filler, helping provide suitable bulk and processing characteristics to a formulation.
Lactose is available in different physical and crystalline forms. Lactose Monohydrate is defined by USP-NF as the monohydrate of O-β-D-galactopyranosyl-(1→4)-α-D-glucopyranose. Anhydrous Lactose is separately defined by USP-NF and can consist of β-lactose or a mixture of α- and β-lactose.
This distinction is important when selecting a lactose grade because hydration state can affect moisture, density, crystallinity and formulation performance.
Granulation can provide advantages in handling and processing compared with very fine powder forms. Granule size and morphology can influence flow, powder movement, packing and blend behavior.
For pharmaceutical applications, Lactose Granules can be characterized by:
Exact numerical values for these characteristics should be taken from the approved product specification or certificate of analysis.
Lactose Monohydrate contains one molecule of water of crystallization. USP-NF identifies Lactose Monohydrate as a specific crystalline form of lactose.
Anhydrous Lactose is a separate USP-NF article. USP describes Anhydrous Lactose as β-lactose or a mixture of β-lactose and α-lactose.
For this reason, a commercial Lactose Granules page should not claim “lactose monohydrate” or “anhydrous lactose” unless the actual SDP product specification confirms the form.
Lactose occurs as a white to creamy-white crystalline material. FCC describes lactose as soluble in water, very slightly soluble in alcohol, and insoluble in chloroform and ether.
For granulated lactose, the finished appearance can differ from the underlying crystalline powder because of the granulation process.
Particle-size distribution is particularly relevant for granulated excipients because it can influence flow, packing and formulation processing. Where the product is designed for a specific processing application, particle-size specifications should be established from the actual product data.
Lactose Granules can be used in the development of oral solid formulations where lactose is required as a filler or diluent. Depending on the grade and formulation design, granulated lactose can contribute to the required mass, handling properties and compression characteristics of the formulation.
Potential formulation applications include:
The suitability of a particular lactose granule grade depends on its particle size, density, flow properties, moisture and compatibility with the other formulation components.
Granulated excipients are often selected to improve powder handling and processing characteristics. Lactose Granules can be evaluated for bulk density, tapped density, flow behavior and particle-size distribution.
These characteristics can influence hopper discharge, material transfer, blending and die filling during pharmaceutical manufacturing.
However, there is no single universal density or particle-size specification applicable to every Lactose Granules product. These parameters should therefore be reported according to the actual grade and manufacturing specification.
Moisture control is an important quality attribute for lactose. The appropriate moisture specification depends on whether the product is lactose monohydrate, anhydrous lactose or another defined lactose grade.
USP harmonization material for Lactose Monohydrate describes water by Karl Fischer and loss on drying as separate tests, demonstrating that these measurements should not automatically be treated as interchangeable.
Accordingly, the CMS “Water Content” and “Loss on Drying” fields should be populated according to the actual specification rather than duplicating one value into both fields.
Pharmaceutical-grade Lactose Granules can be evaluated using identity, assay-related carbohydrate testing, moisture, residue on ignition, optical rotation, microbial quality and other applicable quality attributes.
USP harmonization documentation for lactose includes requirements and discussion covering water, loss on drying, residue on ignition, specific optical rotation and microbial limits.
The appropriate specification depends on the lactose form and applicable pharmacopoeial standard.
Where USP/NF compliance is claimed, the actual material should comply with the current applicable USP-NF monograph. Lactose Monohydrate and Anhydrous Lactose are separate USP-NF articles and should not be treated as identical specifications.
During formulation development, Lactose Granules may be evaluated for particle size, density, moisture, flow, compressibility and compatibility with other excipients.
The choice between lactose monohydrate and anhydrous lactose can influence formulation behavior because the two forms have different hydration states and physical characteristics.
For a granulated product, additional properties such as granule-size distribution and fines content may be important.
Formulators should select the grade according to the intended manufacturing process and dosage-form requirements.
Lactose Granules can be considered for pharmaceutical applications including:
The final application depends on the specific lactose grade and formulation requirements.
The finished Lactose Granules should be tested against the applicable product specification. Important characteristics can include identification, lactose content, moisture, loss on drying, residue on ignition, specific optical rotation, particle-size distribution and microbial quality.
For the exact commercial product, values for particle size, bulk density, tapped density and flow should come from the actual certificate of analysis rather than generic industry values.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.2% |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |
| Water Content | NMT 0.5% |